Top 19 Principia Biopharma investors
The most complete profiles first. Showing 19 of 19.
Jonathan LeffVerified
Venture Capital, Investor · United States
SeedSeries BHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more
Verified email available
Sarah BhagatVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Alan ColowickVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Douglas CrawfordVerified
Venture Capital · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Symbiome, Caribou Biosciences, Calithera Biosciences, Bolt Threads and 18 more
Verified email available
Jason PittsVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Matthew FoyVerified
Corporate Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Semprus BioSciences, Pulmocide, Syntaxin, CRISPR Therapeutics and 50 more
Verified email available
Mike PowellVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Verified email available
Ron HuntVerified
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Verified email available
Maha Katabi, PhD, CFA
Hedge Fund, Venture Capital, Investor · Canada
SeedHealth CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more
Contact details available
Perry Nisen
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Alfred Yue
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
Craig Slutzkin
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Hooman Shahlavi
Hedge Fund, Venture Capital · United States
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more
Contact details available
James Niedel
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Jeffrey Ives
Venture Capital · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Rebecca Luse
Venture Capital · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Robert Blazej
Venture Capital · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Symbiome, Caribou Biosciences, Calithera Biosciences, Bolt Threads and 18 more
Contact details available
Vijay Lathi
Venture Capital, Private Equity Firm · United States
Health CareCybersecurityMessagingWomen FoundedPortfolio: iRhythm Technologies, Braeburn, Direct Flow Medical, Edgewise Therapeutics and 56 more
Contact details available
Mike Dybbs
Venture Capital, Investor · United States
Series BBiotechnologyElectronic Health Records (EHR)Portfolio: Versartis, Principia Biopharma, Nkarta Therapeutics, Advanced Cell Diagnostics and 3 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Principia Biopharma investors are on Angel Roster?
Angel Roster lists 19 Principia Biopharma investors. 8 of them (42%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (18), Private Equity Firms (4) and Hedge Funds (2). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Principia Biopharma investors invest in?
Among those that list a stage, the most common are Seed (4) and Series B (2).
Where are Principia Biopharma investors based?
Most are based in the United States (17), Canada (1) and the United Kingdom (1).
Which companies have Principia Biopharma investors backed?
The most-backed portfolio companies among them are Versartis (16), Neurana Pharmaceuticals (15), Iterum Therapeutics (15), ObsEva (15) and Edge Therapeutics (15).
How do I contact Principia Biopharma investors?
Create a free Angel Roster account to search and filter all 19, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.